2m 2m 2m 2m 2m 2m 2m
BRIACELL THERAP (BCTX)
NASDAQ
$2.99-$0.005 (-0.17%)
Price as of Jun 23, 2026 7:24 PM EDT- $26.2MMarket Cap
- -89.55%1-Year Change
- BiotechnologyIndustry
BRIACELL THERAP (BCTX)
$2.99-$0.005 (-0.17%)
BCTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.99 | ||
Change | +$0.11 (+3.79%) | ||
Open | $3.01 | ||
High | $3.16 | ||
Low | $2.97 | ||
Previous Close | $3.01 | ||
Volume | 123,348 | ||
30-Day Average Volume | 201,873 | ||
1-Week Change | 9.85% | ||
1-Month Change | -13.75% | ||
1-Year Change | -89.55% | ||
3-Year Change | -99.66% | ||
5-Year Change | -99.62% | ||
Fundamentals | |||
Shares Outstanding | 8.7M | ||
Total Assets | $27.1M | ||
Market Cap | $26.2M | ||
Enterprise Value | $19.3M | ||
Period: QTR TTM FY | |||
Revenue | $137,830.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $21.8M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 140 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/25/2025 | ||
Earnings & Revenue